Jacob Manuel, MD
Orthopaedic Surgery · Austin, TXNPI 1063628964
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (32.4%), royalties or licence payments and speaking fees — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 77.3% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $52,559 and has fallen 99.2% since, to $445 in 2025. Among orthopaedic surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 132 payments — averaging $493.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$50K
- Orthalign Inc$13K
- Stryker$1K
- Pacira Pharmaceuticals Incorporated$95
- Biocomposites Inc$31
- Innovation Technologies Inc$25
- plus $129 from 7 others
Across 47 payments — averaging $1780.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$84K
What the payments were for
- Royalty or licence$20,00031%
- Consulting fees$21,10632%
- Speaking & faculty fees$16,34325%
- Travel & lodging$3,0205%
- Food & beverage$4,6817%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 73 | $50,331 |
| Orthalign Inc | 9 | $13,354 |
| Stryker | 37 | $1,185 |
| Pacira Pharmaceuticals Incorporated | 4 | $95 |
| Biocomposites Inc | 1 | $31 |
| Innovation Technologies Inc | 1 | $25 |
| Fidia Pharma USA Inc. | 1 | $24 |
| Si-bone, Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $20 |
| KCI USA, Inc. | 1 | $20 |
| Heron Therapeutics, Inc. | 1 | $16 |
| Abbott | 1 | $15 |
| Pacira Therapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OrthAlign Plus System$12,750
- Journey II$12,396
- VISIONAIRE Solutions$9,450
- REAL INTELLIGENCE$5,660
- Legion Revision$3,100
- Journey II BCS$2,956
- Oxinium Hips$2,844
- Journey II XR$1,937
- Navio Surgical System$1,937
- Legion$1,660
- REDAPT Revision Hip System$1,440
- Journey II CR$1,050
- Engage Partial Knee System$963
- RI.HIP NAVIGATION$963
- ORTHALIGN PLUS$535
- ZUK Uni$496
- POLARSTEM$496
- CORI$252
- MAKO$170
- TRIATHLON$154
How this compares
$65,150 in reported general payments places this provider in the 90th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 163 | $1,992 |
| Celecoxib | 86 | $1,326 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 68 | $852 |
| Oxycodone Hcl | 55 | $407 |
| Methylprednisolone | 38 | $186 |
| Ondansetron Hcl | 29 | $151 |
| Pantoprazole Sodium | 33 | $100 |
| Meloxicam | 27 | $54 |
| Tramadol Hcl | 13 | $49 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Austin
- Robert GrahamAustin$6.3M
- Eric HeinrichAustin$907K
- David DodginAustin$704K
- Stephen BurkhartSan Antonio$185.3M
- Kirby HittTemple$9.1M
- Richard JonesDallas$6.3M
- Stefan KreuzerHouston$6.2M
- Michael WirthSan Antonio$4.5M
- Stephen IncavoHouston$4.3M
- Thomas EdwardsHouston$4.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.